The enteral medical nutrition market in Asia Pacific is expected to grow from US$ 1,057.41million in 2022 to US$ 1,641.69 million by 2028. It is estimated to grow at a CAGR of 5.9% from 2022 to 2028.

Use of Next Generation Technology for Proper Enteral Nutrition Feeding

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient’s nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.

Market Overview

Asia Pacific is the fastest-growing regional market for enteral medical nutrition and is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC. The factors contributing to the growth of the enteral nutrition market in these countries are the rising prevalence of chronic diseases and the growing presence of market players across the country, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth.

The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the healthcare sector. In addition, the governments of these countries are increasing their efforts for enteral nutrition across the country. Also, the rise in the incidence of chronic diseases and the growing awareness regarding enteral nutrition will likely provide greater growth opportunities to the market players in the coming years.

Asia Pacific Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Enteral Medical Nutrition Market Segmentation

The Asia Pacific enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.

Based on indication, the Asia Pacific enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the Asia Pacific enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the Asia Pacific enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the Asia Pacific enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the Asia Pacific Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the Asia Pacific enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Enteral Medical Nutrition Market – By Indication
1.3.2 APAC Enteral Medical Nutrition Market – By Nutrition Type
1.3.3 APAC Enteral Medical Nutrition Market – By Form
1.3.4 APAC Enteral Medical Nutrition Market – By Product
1.3.5 APAC Enteral Medical Nutrition Market – By Distribution Channel
1.3.6 APAC Enteral Medical Nutrition Market – By Age Group
1.3.7 APAC Enteral Medical Nutrition Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Enteral Medical Nutrition Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Enteral Medical Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Cachexia
5.1.2 Rise in Prevalence of Gastrointestinal Diseases
5.2 Market Restraints
5.2.1 Complications of Enteral Nutrition
5.3 Market Opportunities
5.3.1 Use of Next Generation Technology for Proper Enteral Nutrition Feeding
5.4 Future Trends
5.4.1 Developments Related to Enteral Medical Nutrition Products
5.5 Impact Analysis
6. Enteral Medical Nutrition Market – APAC Analysis
6.1 APAC Enteral Medical Nutrition Market Revenue Forecast and Analysis
7. Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Indication
7.1 Overview
7.2 APAC Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)
7.3 Respiratory Disorders
7.3.1 Overview
7.3.2 Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)
7.3.3 Chronic Obstructive Pulmonary Disease
7.3.3.1 Overview
7.3.3.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Respiratory Failure
7.3.4.1 Overview
7.3.4.2 Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)
7.3.5 Cystic Fibrosis
7.3.5.1 Overview
7.3.5.2 Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer
7.4.1 Overview
7.4.2 Cancer Market Revenue and Forecast to 2028 (US$ Million)
7.4.3 Cancer Cachexia
7.4.3.1 Overview
7.4.3.2 Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)
7.4.4 Cachexia with COPD
7.4.4.1 Overview
7.4.4.2 Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.5 Post COVID-19
7.5.1 Overview
7.5.2 Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
7.6 Gastrointestinal Disorders
7.6.1 Overview
7.6.2 Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)
7.6.3 Bowel Obstruction
7.6.3.1 Overview
7.6.3.2 Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)
7.6.4 Crohn’s Disease
7.6.4.1 Overview
7.6.4.2 Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)
7.6.5 Short Bowel Syndrome
7.6.5.1 Overview
7.6.5.2 Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)
7.6.6 Others
7.6.6.1 Overview
7.6.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.7 Liver Failure
7.7.1 Overview
7.7.2 Liver Failure Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Other Market Revenue and Forecast to 2028 (US$ Million)
8. APAC Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Nutrition Type
8.1 Overview
8.2 APAC Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)
8.3 Supplemental
8.3.1 Overview
8.3.2 Supplemental Market Revenue and Forecast to 2028 (US$ Million)
8.4 Sole-Source
8.4.1 Overview
8.4.2 Sole-Source Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Form
9.1 Overview
9.2 APAC Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)
9.3 Powder
9.3.1 Overview
9.3.2 Powder Market Revenue and Forecast to 2028 (US$ Million)
9.4 Liquid
9.4.1 Overview
9.4.2 Liquid Market Revenue and Forecast to 2028 (US$ Million)
9.5 Semi-Solid
9.5.1 Overview
9.5.2 Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Product
10.1 Overview
10.2 APAC Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)
10.3 Standard Protein Diet
10.3.1 Overview
10.3.2 Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.4 High Protein Diet
10.4.1 Overview
10.4.2 High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.5 Fruit Juice Based Oral Nutritional Supplement
10.5.1 Overview
10.5.2 Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Other Market Revenue and Forecast to 2028 (US$ Million)
11. APAC Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 APAC Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. APAC Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Age Group
12.1 Overview
12.2 APAC Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)
12.3 Child (Till 18 Years)
12.3.1 Overview
12.3.2 Child Market Revenue and Forecast to 2028 (US$ Million)
12.4 Adult (Above 18+ Years)
12.4.1 Overview
12.4.2 Adult Market Revenue and Forecast to 2028 (US$ Million)
13. APAC Enteral Medical Nutrition Market Revenue and Forecasts to 2028 – Country Analysis
13.1 Overview
13.1.1 APAC: Enteral Medical Nutrition Market Revenue and Forecasts to 2028, By Country (%)
13.1.1.1 China: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 China: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.1.3 China: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.1.3.1 China: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.1.3.2 China: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.1.3.3 China: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.1.4 China: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.1.5 China: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.1.6 China: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.1.7 China: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.1.8 China: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.2 Japan: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 Japan: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.2.3 Japan: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.2.3.1 Japan: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.2.3.2 Japan: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.2.3.3 Japan: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.2.4 Japan: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.2.5 Japan: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.2.6 Japan: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.2.7 Japan: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.2.8 Japan: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.3 India Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 India: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.3.3 India: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.3.3.1 India: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.3.3.2 India: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.3.3.3 India: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.3.4 India: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.3.5 India: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.3.6 India: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.3.7 India: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.3.8 India: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.4 South Korea: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.4.1 Overview
13.1.1.4.2 South Korea: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.4.3 South Korea: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.4.3.1 South Korea: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.4.3.2 South Korea: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.4.3.3 South Korea: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.4.4 South Korea: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.4.5 South Korea: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.4.6 South Korea: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.4.7 South Korea: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.4.8 South Korea: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.5 Australia: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.5.1 Overview
13.1.1.5.2 Australia: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
13.1.1.5.3 Australia: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.5.3.1 Australia: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.5.3.2 Australia: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.5.3.3 Australia: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.5.4 Australia: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.5.5 Australia: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.5.6 Australia: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.5.7 Australia: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.5.8 Australia: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.6 Rest of APAC: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.1 Overview
13.1.1.6.2 Rest of APAC: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.3 Rest of APAC: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.6.3.1 Rest of APAC: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.6.3.2 Rest of APAC: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.6.3.3 Rest of APAC: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.6.4 Rest of APAC: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.6.5 Rest of APAC: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.6.6 Rest of APAC: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.6.7 Rest of APAC: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.6.8 Rest of APAC: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
14. Enteral Medical Nutrition Market– Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Abbott Laboratories
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Nutricia
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Fresenius Kabi AG
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 B. Braun Melsungen AG
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Nestlé S.A.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Meiji Holdings Co., Ltd.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Smartfish AS
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 DSM Nutritional Products AG
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Hormel Foods Corporation
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Global Health Products, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms in Enteral Medical Nutrition Market

LIST OF TABLES

Table 1. China Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 2. China Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 3. China Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 4. China Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 5. China Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 6. China Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 7. China Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 8. China Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 9. China Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 12. Japan Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 13. Japan Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 14. Japan Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Japan Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 16. Japan Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. Japan Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 18. Japan Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 19. India Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. India Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 21. India Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 22. India Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 23. India Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 24. India Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 25. India Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 26. India Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 27. India Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 28. South Korea Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 29. South Korea Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 30. South Korea Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 31. South Korea Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 32. South Korea Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 33. South Korea Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 34. South Korea Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 35. South Korea Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 36. South Korea Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 37. Australia Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 38. Australia Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 39. Australia Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 40. Australia Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 41. Australia Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 42. Australia Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 43. Australia Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 44. Australia Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 45. Australia Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of APAC Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 47. Rest of APAC Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 48. Rest of APAC Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 49. Rest of APAC Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 50. Rest of APAC Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of APAC Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of APAC Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of APAC Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of APAC Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms in APAC Enteral Medical Nutrition Market

LIST OF FIGURES

Figure 1. APAC Enteral Medical Nutrition Market Segmentation
Figure 2. APAC Enteral Medical Nutrition Market, By Country
Figure 3. APAC Enteral Medical Nutrition Market Overview
Figure 4. Respiratory Disorders Segment Held Largest Share of Indication Segment in APAC Enteral Medical Nutrition Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. APAC Enteral Medical Nutrition Market– Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)
Figure 10. APAC Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)
Figure 11. APAC Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Cancer Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Liver Failure Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)
Figure 28. Supplemental Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Sole-Source Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. APAC Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)
Figure 31. APAC Powder Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. APAC Liquid Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. APAC Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. APAC Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)
Figure 35. APAC Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. APAC High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. APAC Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. APAC Other Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. APAC Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)
Figure 40. APAC Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. APAC Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. APAC Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)
Figure 44. APAC Child Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. APAC Adult Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. APAC: Enteral Medical Nutrition Market Overview, by Country (2022)
Figure 47. APAC: Enteral Medical Nutrition Market Revenue and Forecasts to 2028, By Country (%)
Figure 48. China: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Japan: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. India: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. South Korea: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
Figure 52. Australia: Enteral Medical Nutrition Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Rest of APAC: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Growth Strategies Done by the Companies in the Market, (%)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific enteral medical nutrition market
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific enteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the enteral medical nutrition market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

The List of Companies – Asia Pacific Enteral Medical Nutrition Market

● Abbott Laboratories
● B. Braun Melsungen AG
● DSM Nutritional Products AG
● Fresenius Kabi AG
● Global Health Products, Inc.
● Hormel Foods Corporation
● Meiji Holdings Co., Ltd.
● Nestlé S.A.
● Nutricia
● Smartfish AS

At 7.6% CAGR, the Asia Pacific Enteral Medical Nutrition Market is speculated to be worth US$ 1,641.69 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Asia Pacific enteral medical nutrition market was valued at US$ 1,057.41 million in 2022 and is expected to reach US$ 1,641.69 million by 2028, registering an annual growth rate of 7.6% from 2022 to 2028. Increase in prevalence of cachexia and rise in prevalence of gastrointestinal diseases are the critical factors attributed to the market expansion.

The enteral medical nutrition market players are adopting various strategies, including new product launches, regional expansion, and introduction of various programs for use of enteral nutrition to treat patients, to increase their market share. Enteral medical nutrition is becoming safe and highly effective with continued innovation and technological advances, leading to increased acceptance. Therefore, leading players are significantly investing in R&D to develop advanced products and gain more revenue share.

In June 2020, Otsuka Pharmaceutical Factory Inc. launched ENORAS Liquid in strawberry and coffee flavors for enteral use. The product is a concentrated (1.6 kcal/mL) polymeric enteric nutrition formula based on the latest nutritional information to efficiently provide nutrients and energy in a small amount. It is designed to administer 300 kcal per pouch, which is approximately a third of the recommended daily number of vitamins, and trace elements specified in Dietary Reference Intakes for Japanese.

On the contrary, complications of enteral nutrition hurdle the growth of Asia Pacific enteral medical nutrition market.

Based on indication, the Asia Pacific enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. Respiratory disorders held 41.8% market share in 2022, amassing US$ 441.81 million. It is projected to garner US$ 664.13 million by 2028 to expand at 7.0% CAGR during 2022–2028. Based on nutrition type, the Asia Pacific enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 77.4% market share in 2022, amassing US$ 818.17 million. It is projected to garner US$ 1,253.54 million by 2028 to expand at 7.4% CAGR during 2022–2028. Based on form, the Asia Pacific enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held 54.6% market share in 2022, amassing US$ 577.06 million. It is projected to garner US$ 911.35 million by 2028 to expand at 7.9% CAGR during 2022–2028. Based on product, the Asia Pacific enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held 52.5% market share in 2022, amassing US$ 559.59 million. It is projected to garner US$ 849.08 million by 2028 to expand at 7.3% CAGR during 2022–2028. Based on distribution channel, the Asia Pacific Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held 60.8% market share in 2022, amassing US$ 643.20 million. It is projected to garner US$ 988.92 million by 2028 to expand at 7.4% CAGR during 2022–2028. Based on Age Group, the Asia Pacific enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). With 90.2% share of the domain, the adults segment dominated the market in 2022. It accrued US$ 953.96 million in 2022 and is estimated to generate US$ 1,469.01 million by 2028 to grow at a CAGR of 7.5% over the forecast period. Our regional analysis states that China captured 29.5% market share in 2022. It was assessed at US$ 309.29 million in 2022 and is likely to hit US$ 475.27 million by 2028, exhibiting a CAGR of 7.4% during the forecast period.

Key players dominating the Asia Pacific enteral medical nutrition market are Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS among others.